Technical Analysis for REVB - Revelation Biosciences, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
NR7 | Range Contraction | 0.72% | |
NR7-2 | Range Contraction | 0.72% | |
Narrow Range Bar | Range Contraction | 0.72% | |
Inside Day | Range Contraction | 0.72% | |
Wide Bands | Range Expansion | 0.72% | |
NR7 | Range Contraction | 1.69% | |
Inside Day | Range Contraction | 1.69% | |
Wide Bands | Range Expansion | 1.69% | |
Wide Bands | Range Expansion | 2.68% | |
Wide Bands | Range Expansion | -6.03% |
Alert | Time |
---|---|
10 DMA Support | about 2 hours ago |
60 Minute Opening Range Breakout | about 2 hours ago |
Rose Above Previous Day's High | about 2 hours ago |
Outside Day | about 2 hours ago |
Up 3% | about 2 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/20/2024
Revelation Biosciences, Inc. Description
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. Revelation has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. In addition to Revelation’s therapeutic pipeline, Revelation is also developing REVDx-501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Disease Immunology Infection Vaccination Respiratory Diseases Allergology Nasal Administration Rhinitis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 39.0 |
52 Week Low | 1.7801 |
Average Volume | 199,957 |
200-Day Moving Average | 14.55 |
50-Day Moving Average | 2.71 |
20-Day Moving Average | 2.34 |
10-Day Moving Average | 2.10 |
Average True Range | 0.30 |
RSI (14) | 38.65 |
ADX | 9.18 |
+DI | 21.09 |
-DI | 23.77 |
Chandelier Exit (Long, 3 ATRs) | 2.06 |
Chandelier Exit (Short, 3 ATRs) | 2.68 |
Upper Bollinger Bands | 2.89 |
Lower Bollinger Band | 1.78 |
Percent B (%b) | 0.28 |
BandWidth | 47.26 |
MACD Line | -0.29 |
MACD Signal Line | -0.34 |
MACD Histogram | 0.0504 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.26 | ||||
Resistance 3 (R3) | 2.26 | 2.20 | 2.23 | ||
Resistance 2 (R2) | 2.20 | 2.16 | 2.20 | 2.22 | |
Resistance 1 (R1) | 2.15 | 2.14 | 2.12 | 2.15 | 2.21 |
Pivot Point | 2.09 | 2.09 | 2.08 | 2.09 | 2.09 |
Support 1 (S1) | 2.04 | 2.05 | 2.01 | 2.04 | 1.97 |
Support 2 (S2) | 1.98 | 2.03 | 1.98 | 1.96 | |
Support 3 (S3) | 1.93 | 1.98 | 1.95 | ||
Support 4 (S4) | 1.93 |